PAK1 is a novel cardiac protective signaling molecule

Front Med. 2014 Dec;8(4):399-403. doi: 10.1007/s11684-014-0380-9. Epub 2014 Nov 22.

Abstract

We review here the novel cardiac protective effects of the multifunctional enzyme, p21-activated kinase 1 (PAK1), a member of a serine/threonine protein kinase family. Despite the large body of evidence from studies in noncardiac tissue indicating that PAK1 activity is key in the regulation of a number of cellular functions, the role of PAK1 in the heart has only been revealed over the past few years. In this review, we assemble an overview of the recent findings on PAK1 signaling in the heart, particularly its cardiac protective effects. We present a model for PAK1 signaling that provides a mechanism for specifically affecting cardiac cellular processes in which regulation of protein phosphorylation states by protein phosphatase 2A (PP2A) predominates.We discuss the anti-adrenergic and antihypertrophic cardiac protective effects of PAK1, as well as its role in maintaining ventricular Ca(2+) homeostasis and electrophysiological stability under physiological, β-adrenergic and hypertrophic stress conditions.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Heart / physiology*
  • Homeostasis / genetics
  • Homeostasis / physiology
  • Humans
  • Mice
  • Signal Transduction / genetics*
  • Signal Transduction / physiology*
  • p21-Activated Kinases / genetics*
  • p21-Activated Kinases / physiology*

Substances

  • p21-Activated Kinases